25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIOS (Biosenic) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biosenic together

I guess you are interested in BioSenic S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Biosenic’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Biosenic’s Price Targets

I'm going to help you getting a better view of BioSenic S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioSenic S.A.

I send you an email if I find something interesting about BioSenic S.A..

1. Quick Overview

1.1. Quick analysis of Biosenic (30 sec.)










1.2. What can you expect buying and holding a share of Biosenic? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
€-0.03
Expected worth in 1 year
€-0.19
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
€-0.16
Return On Investment
-6,880.5%

For what price can you sell your share?

Current Price per Share
€0.00
Expected price per share
€0.002 - €0.0032
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biosenic (5 min.)




Live pricePrice per Share (EOD)
€0.00
Intrinsic Value Per Share
€-0.11 - €0.21
Total Value Per Share
€-0.14 - €0.18

2.2. Growth of Biosenic (5 min.)




Is Biosenic growing?

Current yearPrevious yearGrowGrow %
How rich?-$26.6m$3.6m-$30.3m-113.8%

How much money is Biosenic making?

Current yearPrevious yearGrowGrow %
Making money-$33.7m-$2.3m-$31.3m-92.9%
Net Profit Margin-5,299.8%-767.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Biosenic (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biosenic?

Welcome investor! Biosenic's management wants to use your money to grow the business. In return you get a share of Biosenic.

First you should know what it really means to hold a share of Biosenic. And how you can make/lose money.

Speculation

The Price per Share of Biosenic is €0.0023. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biosenic.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biosenic, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.03. Based on the TTM, the Book Value Change Per Share is €-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is €0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biosenic.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps-0.05-2,250.2%-0.05-2,250.2%0.00-159.6%-0.03-1,140.1%-0.02-1,034.4%-0.02-985.1%
Usd Book Value Change Per Share-0.05-2,019.6%-0.05-2,019.6%0.02773.2%-0.02-678.4%-0.01-425.3%0.00-178.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.001.9%
Usd Total Gains Per Share-0.05-2,019.6%-0.05-2,019.6%0.02773.2%-0.02-678.4%-0.01-425.3%0.00-176.1%
Usd Price Per Share0.07-0.07-0.11-0.32-1.66-5.47-
Price to Earnings Ratio-1.39--1.39--30.71--21.91--87.08--233.07-
Price-to-Total Gains Ratio-1.55--1.55-6.34--12.77-63.37-139.57-
Price to Book Ratio-1.76--1.76-20.06--15.32-325.30-519.43-
Price-to-Total Gains Ratio-1.55--1.55-6.34--12.77-63.37-139.57-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.00270043
Number of shares370311
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.05-0.01
Usd Total Gains Per Share-0.05-0.01
Gains per Quarter (370311 shares)-17,201.17-3,622.31
Gains per Year (370311 shares)-68,804.66-14,489.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-68805-688150-14489-14499
20-137609-1376200-28978-28988
30-206414-2064250-43468-43477
40-275219-2752300-57957-57966
50-344023-3440350-72446-72455
60-412828-4128400-86935-86944
70-481633-4816450-101425-101433
80-550437-5504500-115914-115922
90-619242-6192550-130403-130411
100-688047-6880600-144892-144900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.012.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%5.07.00.041.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%4.00.06.040.0%4.00.08.033.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%5.07.00.041.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BioSenic S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.040-0.0400%0.015-361%-0.013-66%-0.008-79%-0.003-91%
Book Value Per Share---0.035-0.0350%0.005-827%-0.013-61%-0.006-82%0.003-1245%
Current Ratio--0.1170.1170%0.447-74%0.902-87%1.177-90%1.626-93%
Debt To Asset Ratio--3.3753.3750%0.893+278%1.870+80%1.477+129%1.155+192%
Debt To Equity Ratio----0%7.431-100%2.477-100%4.767-100%4.045-100%
Dividend Per Share----0%-0%-0%-0%0.000-100%
Enterprise Value--7808155.3797808155.3790%38320753.536-80%155036003.857-95%904731460.298-99%3369108747.135-100%
Eps---0.044-0.0440%-0.003-93%-0.022-49%-0.020-54%-0.019-56%
Ev To Ebitda Ratio---1.149-1.1490%-16.971+1377%-167.683+14495%-194.173+16800%-335.545+29105%
Ev To Sales Ratio--14.38014.3800%144.063-90%192.474-93%567.000-97%19436.365-100%
Free Cash Flow Per Share---0.005-0.0050%-0.003-45%-0.009+77%-0.014+161%-0.016+198%
Free Cash Flow To Equity Per Share---0.003-0.0030%-0.001-50%-0.004+49%-0.004+53%-0.001-56%
Gross Profit Margin--0.9980.9980%1.0000%0.9990%1.0000%1.0000%
Intrinsic Value_10Y_max--0.211----------
Intrinsic Value_10Y_min---0.108----------
Intrinsic Value_1Y_max---0.003----------
Intrinsic Value_1Y_min---0.015----------
Intrinsic Value_3Y_max--0.010----------
Intrinsic Value_3Y_min---0.041----------
Intrinsic Value_5Y_max--0.044----------
Intrinsic Value_5Y_min---0.064----------
Market Cap1501582.637-2561%39955155.37939955155.3790%62674753.536-36%179145337.190-78%922911860.298-96%3043198772.421-99%
Net Profit Margin---52.998-52.9980%-7.673-86%-24.532-54%-17.107-68%-42.385-20%
Operating Margin---12.947-12.9470%-8.714-33%-7.513-42%-7.509-42%-36.073+179%
Operating Ratio--14.39614.3960%8.940+61%12.125+19%10.478+37%39.053-63%
Pb Ratio-0.066+96%-1.760-1.7600%20.062-109%-15.323+771%325.298-101%519.429-100%
Pe Ratio-0.052+96%-1.388-1.3880%-30.708+2112%-21.912+1478%-87.077+6172%-233.073+16687%
Price Per Share0.002-2561%0.0610.0610%0.096-36%0.274-78%1.414-96%4.661-99%
Price To Free Cash Flow Ratio-0.433+96%-11.514-11.5140%-32.728+184%-25.904+125%-80.969+603%-235.165+1942%
Price To Total Gains Ratio-0.058+96%-1.547-1.5470%6.338-124%-12.767+725%63.372-102%139.567-101%
Quick Ratio--0.0540.0540%0.408-87%0.767-93%1.084-95%1.573-97%
Return On Assets---3.011-3.0110%-0.070-98%-1.245-59%-0.936-69%-0.659-78%
Return On Equity----0%-0.5790%-0.1930%-1.8560%-1.9150%
Total Gains Per Share---0.040-0.0400%0.015-361%-0.013-66%-0.008-79%-0.003-91%
Usd Book Value---26657940.500-26657940.5000%3667888.400-827%-10310946.200-61%-4924879.860-82%2328592.530-1245%
Usd Book Value Change Per Share---0.046-0.0460%0.018-361%-0.016-66%-0.010-79%-0.004-91%
Usd Book Value Per Share---0.041-0.0410%0.006-827%-0.016-61%-0.008-82%0.004-1245%
Usd Dividend Per Share----0%-0%-0%-0%0.000-100%
Usd Enterprise Value--9167555.2319167555.2310%44992396.727-80%182027772.129-95%1062245207.536-99%3955670580.011-100%
Usd Eps---0.052-0.0520%-0.004-93%-0.026-49%-0.024-54%-0.023-56%
Usd Free Cash Flow---4074127.000-4074127.0000%-2248401.500-45%-7191753.867+77%-10628188.020+161%-12125752.570+198%
Usd Free Cash Flow Per Share---0.006-0.0060%-0.003-45%-0.011+77%-0.016+161%-0.019+198%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%-0.002-50%-0.005+49%-0.005+53%-0.001-56%
Usd Market Cap1763008.174-2561%46911347.93146911347.9310%73586428.127-36%210334540.395-78%1083590815.176-96%3573019678.700-99%
Usd Price Per Share0.003-2561%0.0720.0720%0.113-36%0.322-78%1.660-96%5.473-99%
Usd Profit---33788249.800-33788249.8000%-2396338.100-93%-17119943.467-49%-15532168.900-54%-14791546.620-56%
Usd Revenue--637536.300637536.3000%312310.600+104%707982.300-10%659609.380-3%793221.960-20%
Usd Total Gains Per Share---0.046-0.0460%0.018-361%-0.016-66%-0.010-79%-0.004-91%
 EOD+2 -6MRQTTM+0 -0YOY+5 -323Y+9 -285Y+9 -2810Y+9 -30

3.3 Fundamental Score

Let's check the fundamental score of BioSenic S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.052
Price to Book Ratio (EOD)Between0-1-0.066
Net Profit Margin (MRQ)Greater than0-52.998
Operating Margin (MRQ)Greater than0-12.947
Quick Ratio (MRQ)Greater than10.054
Current Ratio (MRQ)Greater than10.117
Debt to Asset Ratio (MRQ)Less than13.375
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.011
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of BioSenic S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.012
Ma 20Greater thanMa 500.002
Ma 50Greater thanMa 1000.002
Ma 100Greater thanMa 2000.002
OpenGreater thanClose0.002
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About BioSenic S.A.

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

Fundamental data was last updated by Penke on 2025-06-19 08:25:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Biosenic earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Biosenic to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -5,299.8%Β means thatΒ €-53.00 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioSenic S.A.:

  • The MRQ is -5,299.8%. The company is making a huge loss. -2
  • The TTM is -5,299.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-5,299.8%TTM-5,299.8%0.0%
TTM-5,299.8%YOY-767.3%-4,532.5%
TTM-5,299.8%5Y-1,710.7%-3,589.1%
5Y-1,710.7%10Y-4,238.5%+2,527.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5,299.8%-92.7%-5,207.1%
TTM-5,299.8%-140.3%-5,159.5%
YOY-767.3%-196.4%-570.9%
3Y-2,453.2%-248.5%-2,204.7%
5Y-1,710.7%-343.4%-1,367.3%
10Y-4,238.5%-496.2%-3,742.3%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Biosenic is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Biosenic to theΒ Biotechnology industry mean.
  • -301.1% Return on Assets means thatΒ Biosenic generatedΒ €-3.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioSenic S.A.:

  • The MRQ is -301.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -301.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-301.1%TTM-301.1%0.0%
TTM-301.1%YOY-7.0%-294.1%
TTM-301.1%5Y-93.6%-207.4%
5Y-93.6%10Y-65.9%-27.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-301.1%-11.6%-289.5%
TTM-301.1%-11.6%-289.5%
YOY-7.0%-11.4%+4.4%
3Y-124.5%-11.8%-112.7%
5Y-93.6%-12.0%-81.6%
10Y-65.9%-13.7%-52.2%
4.3.1.3. Return on Equity

Shows how efficient Biosenic is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Biosenic to theΒ Biotechnology industry mean.
  • 0.0% Return on Equity means Biosenic generated €0.00Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioSenic S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-57.9%+57.9%
TTM-5Y-185.6%+185.6%
5Y-185.6%10Y-191.5%+5.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.6%+13.6%
TTM--15.0%+15.0%
YOY-57.9%-14.5%-43.4%
3Y-19.3%-16.9%-2.4%
5Y-185.6%-17.5%-168.1%
10Y-191.5%-19.9%-171.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BioSenic S.A..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Biosenic is operatingΒ .

  • Measures how much profit Biosenic makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Biosenic to theΒ Biotechnology industry mean.
  • An Operating Margin of -1,294.7%Β means the company generated €-12.95 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioSenic S.A.:

  • The MRQ is -1,294.7%. The company is operating very inefficient. -2
  • The TTM is -1,294.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,294.7%TTM-1,294.7%0.0%
TTM-1,294.7%YOY-871.4%-423.2%
TTM-1,294.7%5Y-750.9%-543.8%
5Y-750.9%10Y-3,607.3%+2,856.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,294.7%-229.2%-1,065.5%
TTM-1,294.7%-249.0%-1,045.7%
YOY-871.4%-208.5%-662.9%
3Y-751.3%-223.8%-527.5%
5Y-750.9%-346.1%-404.8%
10Y-3,607.3%-475.5%-3,131.8%
4.3.2.2. Operating Ratio

Measures how efficient Biosenic is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 14.40 means that the operating costs are €14.40 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of BioSenic S.A.:

  • The MRQ is 14.396. The company is inefficient in keeping operating costs low. -1
  • The TTM is 14.396. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.396TTM14.3960.000
TTM14.396YOY8.940+5.456
TTM14.3965Y10.478+3.918
5Y10.47810Y39.053-28.574
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3962.110+12.286
TTM14.3962.684+11.712
YOY8.9403.096+5.844
3Y12.1253.652+8.473
5Y10.4784.745+5.733
10Y39.0536.614+32.439
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BioSenic S.A..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biosenic is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 0.12Β means the company has €0.12 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of BioSenic S.A.:

  • The MRQ is 0.117. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.117. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.1170.000
TTM0.117YOY0.447-0.330
TTM0.1175Y1.177-1.060
5Y1.17710Y1.626-0.450
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1173.661-3.544
TTM0.1173.846-3.729
YOY0.4474.140-3.693
3Y0.9024.688-3.786
5Y1.1775.746-4.569
10Y1.6266.147-4.521
4.4.3.2. Quick Ratio

Measures if Biosenic is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Biosenic to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.05Β means the company can pay off €0.05 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioSenic S.A.:

  • The MRQ is 0.054. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.054. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.054TTM0.0540.000
TTM0.054YOY0.408-0.355
TTM0.0545Y1.084-1.031
5Y1.08410Y1.573-0.488
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0542.826-2.772
TTM0.0543.182-3.128
YOY0.4083.786-3.378
3Y0.7674.311-3.544
5Y1.0845.703-4.619
10Y1.5736.454-4.881
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BioSenic S.A..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BiosenicΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Biosenic to Biotechnology industry mean.
  • A Debt to Asset Ratio of 3.38Β means that Biosenic assets areΒ financed with 337.5% credit (debt) and the remaining percentage (100% - 337.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of BioSenic S.A.:

  • The MRQ is 3.375. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 3.375. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.375TTM3.3750.000
TTM3.375YOY0.893+2.482
TTM3.3755Y1.477+1.898
5Y1.47710Y1.155+0.322
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3750.329+3.046
TTM3.3750.349+3.026
YOY0.8930.331+0.562
3Y1.8700.340+1.530
5Y1.4770.349+1.128
10Y1.1550.379+0.776
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Biosenic is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Biosenic to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioSenic S.A.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY7.431-7.431
TTM-5Y4.767-4.767
5Y4.76710Y4.045+0.722
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.379-0.379
TTM-0.437-0.437
YOY7.4310.414+7.017
3Y2.4770.450+2.027
5Y4.7670.464+4.303
10Y4.0450.515+3.530
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Biosenic generates.

  • Above 15 is considered overpriced butΒ always compareΒ Biosenic to theΒ Biotechnology industry mean.
  • A PE ratio of -1.39 means the investor is paying €-1.39Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioSenic S.A.:

  • The EOD is -0.052. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.388. Based on the earnings, the company is expensive. -2
  • The TTM is -1.388. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.052MRQ-1.388+1.336
MRQ-1.388TTM-1.3880.000
TTM-1.388YOY-30.708+29.319
TTM-1.3885Y-87.077+85.688
5Y-87.07710Y-233.073+145.997
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.052-2.304+2.252
MRQ-1.388-2.080+0.692
TTM-1.388-2.564+1.176
YOY-30.708-3.764-26.944
3Y-21.912-3.773-18.139
5Y-87.077-6.193-80.884
10Y-233.073-6.833-226.240
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioSenic S.A.:

  • The EOD is -0.433. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.514. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.514. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.433MRQ-11.514+11.082
MRQ-11.514TTM-11.5140.000
TTM-11.514YOY-32.728+21.214
TTM-11.5145Y-80.969+69.455
5Y-80.96910Y-235.165+154.195
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.433-3.132+2.699
MRQ-11.514-2.705-8.809
TTM-11.514-3.666-7.848
YOY-32.728-4.405-28.323
3Y-25.904-5.059-20.845
5Y-80.969-8.477-72.492
10Y-235.165-9.304-225.861
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Biosenic is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of -1.76 means the investor is paying €-1.76Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of BioSenic S.A.:

  • The EOD is -0.066. Based on the equity, the company is expensive. -2
  • The MRQ is -1.760. Based on the equity, the company is expensive. -2
  • The TTM is -1.760. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.066MRQ-1.760+1.694
MRQ-1.760TTM-1.7600.000
TTM-1.760YOY20.062-21.822
TTM-1.7605Y325.298-327.058
5Y325.29810Y519.429-194.131
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0661.953-2.019
MRQ-1.7601.843-3.603
TTM-1.7602.112-3.872
YOY20.0622.441+17.621
3Y-15.3232.494-17.817
5Y325.2983.661+321.637
10Y519.4294.311+515.118
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets9,559
Total Liabilities32,264
Total Stockholder Equity-22,912
 As reported
Total Liabilities 32,264
Total Stockholder Equity+ -22,912
Total Assets = 9,559

Assets

Total Assets9,559
Total Current Assets1,846
Long-term Assets7,713
Total Current Assets
Cash And Cash Equivalents 117
Short-term Investments 398
Net Receivables 334
Other Current Assets 1,395
Total Current Assets  (as reported)1,846
Total Current Assets  (calculated)2,244
+/- 398
Long-term Assets
Property Plant Equipment 698
Intangible Assets 2,989
Long-term Assets Other 136
Long-term Assets  (as reported)7,713
Long-term Assets  (calculated)3,823
+/- 3,890

Liabilities & Shareholders' Equity

Total Current Liabilities15,844
Long-term Liabilities16,420
Total Stockholder Equity-22,912
Total Current Liabilities
Short-term Debt 11,821
Short Long Term Debt 11,460
Accounts payable 3,594
Other Current Liabilities 424
Total Current Liabilities  (as reported)15,844
Total Current Liabilities  (calculated)27,299
+/- 11,455
Long-term Liabilities
Long term Debt 15,573
Capital Lease Obligations 1,125
Long-term Liabilities  (as reported)16,420
Long-term Liabilities  (calculated)16,698
+/- 278
Total Stockholder Equity
Common Stock6,275
Retained Earnings -34,887
Accumulated Other Comprehensive Income -20
Other Stockholders Equity 5,720
Total Stockholder Equity (as reported)-22,912
Total Stockholder Equity (calculated)-22,912
+/-0
Other
Capital Stock6,275
Cash and Short Term Investments 117
Common Stock Shares Outstanding 137,038
Current Deferred Revenue5
Liabilities and Stockholders Equity 9,559
Net Debt 28,044
Net Invested Capital 4,121
Net Working Capital -13,998
Property Plant and Equipment Gross 1,067
Short Long Term Debt Total 28,161



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
15,053
14,418
12,811
24,202
50,383
38,585
25,173
25,753
22,393
24,835
19,772
29,324
9,559
9,55929,32419,77224,83522,39325,75325,17338,58550,38324,20212,81114,41815,053
   > Total Current Assets 
13,049
11,767
8,087
19,259
41,701
28,471
14,615
15,000
11,733
18,817
14,291
4,626
1,846
1,8464,62614,29118,81711,73315,00014,61528,47141,70119,2598,08711,76713,049
       Cash And Cash Equivalents 
5,559
4,822
2,440
11,576
33,611
20,300
8,411
8,174
8,633
14,648
9,510
1,846
117
1171,8469,51014,6488,6338,1748,41120,30033,61111,5762,4404,8225,559
       Short-term Investments 
203
0
0
0
0
0
0
0
-140
0
1,200
-111
398
398-1111,2000-1400000000203
       Net Receivables 
0
6,834
5,513
7,498
7,912
8,013
5,938
6,724
3,025
3,841
361
2,490
334
3342,4903613,8413,0256,7245,9388,0137,9127,4985,5136,8340
       Other Current Assets 
7,287
111
134
185
177
158
265
102
74
328
365
2,780
1,395
1,3952,780365328741022651581771851341117,287
   > Long-term Assets 
2,004
2,651
4,724
4,942
8,682
10,114
10,558
10,754
10,660
6,019
5,481
24,698
7,713
7,71324,6985,4816,01910,66010,75410,55810,1148,6824,9424,7242,6512,004
       Property Plant Equipment 
1,137
1,277
2,869
2,667
5,793
6,385
6,302
6,203
6,100
226
863
1,419
698
6981,4198632266,1006,2036,3026,3855,7932,6672,8691,2771,137
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
1,802
0
01,80200000000000
       Long Term Investments 
0
0
282
283
282
291
297
326
472
0
0
0
0
000047232629729128228328200
       Intangible Assets 
0
19
60
53
69
56
30
22
28
28
23
17,293
2,989
2,98917,293232828223056695360190
       Long-term Assets Other 
204
2
462
-1
487
590
1
-1
1
1
97
25
136
136259711-11590487-14622204
> Total Liabilities 
11,241
11,780
12,748
33,687
22,236
23,315
22,790
21,262
20,345
21,510
26,537
26,200
32,264
32,26426,20026,53721,51020,34521,26222,79023,31522,23633,68712,74811,78011,241
   > Total Current Liabilities 
6,400
5,854
6,246
26,359
10,543
10,513
10,598
9,327
9,339
9,790
6,673
10,353
15,844
15,84410,3536,6739,7909,3399,32710,59810,51310,54326,3596,2465,8546,400
       Short-term Debt 
152
192
509
13,116
2,314
1,242
1,251
2,605
2,709
3,077
1,252
8,245
11,821
11,8218,2451,2523,0772,7092,6051,2511,2422,31413,116509192152
       Short Long Term Debt 
0
0
5,561
427
2,280
1,048
1,130
2,499
2,531
3,045
945
4,826
11,460
11,4604,8269453,0452,5312,4991,1301,0482,2804275,56100
       Accounts payable 
789
1,116
1,136
2,853
1,818
2,327
2,808
3,242
3,069
5,171
92
1,990
3,594
3,5941,990925,1713,0693,2422,8082,3271,8182,8531,1361,116789
       Other Current Liabilities 
5,459
4,546
323
-3,207
6,350
4
775
734
2,760
358
150
118
424
4241181503582,76073477546,350-3,2073234,5465,459
   > Long-term Liabilities 
4,841
5,926
6,502
7,328
11,693
12,802
12,192
11,935
11,006
11,720
19,864
15,847
16,420
16,42015,84719,86411,72011,00611,93512,19212,80211,6937,3286,5025,9264,841
       Long term Debt Total 
0
0
0
0
10,118
11,167
10,551
10,247
11,006
0
0
0
0
000011,00610,24710,55111,16710,1180000
       Other Liabilities 
0
1,812
1,450
1,501
1,575
1,636
1,641
1,678
0
0
112
0
0
00112001,6781,6411,6361,5751,5011,4501,8120
> Total Stockholder Equity
3,812
2,637
63
-9,485
28,147
15,270
2,383
4,491
2,048
3,325
-6,765
3,526
-22,912
-22,9123,526-6,7653,3252,0484,4912,38315,27028,147-9,485632,6373,812
   Common Stock
6,943
8,417
9,288
10,466
20,708
20,708
14,663
12,532
5,454
8,415
4,924
4,774
6,275
6,2754,7744,9248,4155,45412,53214,66320,70820,70810,4669,2888,4176,943
   Retained Earnings -34,887-5,723-81,488-73,080-61,586-62,136-55,501-48,773-35,752-21,670-15,860-11,794-8,097
   Capital Surplus 
0
0
0
0
42,670
42,670
42,665
53,478
58,026
0
0
0
0
000058,02653,47842,66542,67042,6700000
   Treasury Stock0000000000000
   Other Stockholders Equity 
4,966
6,014
6,635
1,719
42,670
42,670
42,665
53,478
58,026
67,594
3,970
4,517
5,720
5,7204,5173,97067,59458,02653,47842,66542,67042,6701,7196,6356,0144,966



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue543
Cost of Revenue-234
Gross Profit543309
 
Operating Income (+$)
Gross Profit543
Operating Expense-7,583
Operating Income-7,040-7,040
 
Operating Expense (+$)
Research Development3,741
Selling General Administrative3,651
Selling And Marketing Expenses-44
Operating Expense7,5837,348
 
Net Interest Income (+$)
Interest Income57
Interest Expense-5,954
Other Finance Cost-3,181
Net Interest Income-2,716
 
Pretax Income (+$)
Operating Income-7,040
Net Interest Income-2,716
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-29,02814,948
EBIT - interestExpense = -12,984
-28,785
-22,824
Interest Expense5,954
Earnings Before Interest and Taxes (EBIT)-7,030-23,074
Earnings Before Interest and Taxes (EBITDA)-6,796
 
After tax Income (+$)
Income Before Tax-29,028
Tax Provision--7
Net Income From Continuing Ops-29,021-29,021
Net Income-28,778
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,583
Total Other Income/Expenses Net-21,9882,716
 

Technical Analysis of Biosenic
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biosenic. The general trend of Biosenic is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biosenic's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biosenic Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioSenic S.A..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.003 < 0.0032 < 0.0032.

The bearish price targets are: 0.0022 > 0.002 > 0.002.

Know someone who trades $BIOS? Share this with them.πŸ‘‡

BioSenic S.A. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioSenic S.A.. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioSenic S.A. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioSenic S.A.. The current macd is 0.00011703.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biosenic price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biosenic. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biosenic price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
BioSenic S.A. Daily Moving Average Convergence/Divergence (MACD) ChartBioSenic S.A. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioSenic S.A.. The current adx is 40.75.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biosenic shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
BioSenic S.A. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioSenic S.A.. The current sar is 0.00298631.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BioSenic S.A. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioSenic S.A.. The current rsi is 53.01. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
BioSenic S.A. Daily Relative Strength Index (RSI) ChartBioSenic S.A. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioSenic S.A.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biosenic price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
BioSenic S.A. Daily Stochastic Oscillator ChartBioSenic S.A. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioSenic S.A.. The current cci is 13.62.

BioSenic S.A. Daily Commodity Channel Index (CCI) ChartBioSenic S.A. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioSenic S.A.. The current cmo is 0.43500534.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BioSenic S.A. Daily Chande Momentum Oscillator (CMO) ChartBioSenic S.A. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioSenic S.A.. The current willr is -75.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biosenic is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BioSenic S.A. Daily Williams %R ChartBioSenic S.A. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of BioSenic S.A..

BioSenic S.A. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioSenic S.A.. The current atr is 0.00026033.

BioSenic S.A. Daily Average True Range (ATR) ChartBioSenic S.A. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioSenic S.A.. The current obv is -359,352,669.

BioSenic S.A. Daily On-Balance Volume (OBV) ChartBioSenic S.A. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioSenic S.A.. The current mfi is 68.15.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
BioSenic S.A. Daily Money Flow Index (MFI) ChartBioSenic S.A. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioSenic S.A..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

BioSenic S.A. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioSenic S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.012
Ma 20Greater thanMa 500.002
Ma 50Greater thanMa 1000.002
Ma 100Greater thanMa 2000.002
OpenGreater thanClose0.002
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biosenic with someone you think should read this too:
  • Are you bullish or bearish on Biosenic? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biosenic? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioSenic S.A.

I send you an email if I find something interesting about BioSenic S.A..


Comments

How you think about this?

Leave a comment

Stay informed about BioSenic S.A..

Receive notifications about BioSenic S.A. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.